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Abstract: 
    Twenty four local rabbits were used in this study separated into four groups. 
Ulcerative colitis (UC) was induced in all rabbits by rectal administration of 5% 
glacial acetic acid-30% ethanol (GAA 5%). Animals in the control group were 
orally (p.o) administered with distilled water, group 2 was administered with 
Asacol at a dose of 800 mg/kg BW/day p.o., where as group 3 was given 
ethanolic extract of Chamomile at a dose of 500 mg/kg BW/day p.o, and finally; 
the rabbits of group four were received 1000 mg/kg BW/day p.o of ethanolic 
extract of Haritaki.  
    Each of the above agents was administered two days prior to induction of UC 
(as a single daily dose), the day of induction, and a dose 22 hours post-induction 
(i.e., 2 hours prior to sacrificing of the animal). The effects were observed as 
changes in the serum electrolytes (sodium and potassium), changes in 
haematological aspects including; Total white blood cell count (total WBC), 
lymphocytes count, Red blood cell count (RBC), Blood haemoglobin (HGB), 
and Packed cell volume (PCV%). Besides the examination of gross and 
histopathological changes of the colon segments for all the tested rabbits. 
    In conclusion, GAA 5%-induced colitis in rabbits is preferred for testing the 
anti-inflammatory and anti-ulcer effectiveness of new therapeutic modalities. 
Asacol showed high potent anti-inflammatory and protective effect against 
ulceration and inflammation of colon. As well as, ethanolic extracts of both 
Chamomile and Haritaki have an accepted prophylactic activity against GAA 
5%-induced colitis in rabbits through correction of the changed electrolytes, 
haematological parameters and histopathological signs. 
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Introduction: 
    Ulcerative colitis (UC), is a 
chronic and relapsing inflammatory 
disease caused by the inflammation 
and sores in the lining of large 
intestine (1, 2). Conventional 
therapy for UC includes 
sulfasalazine and other 5-
aminosalicylic acid (5-ASA) type of 
compounds such as mesalazine 
(Asacol)
® 
(3), and in more persistent 
and/or severe cases, oral, rectal and 
parenteral corticosteroids and 
immunosuppressants are 
administered (4). All of these have 
significant toxicities and are partly 
or completely ineffective in 
significant numbers of cases (5). The 
use of medicinal plants or their 
active components with anti-ulcer  
 
activity has become an increasingly 
attractive approach for the treatment 
of UC. Matricaria Chamomilla or 
Matricaria recutita or German 
chamomile, also spelled chamomile, 
is one of the most widely used and 
well-documented medicinal plants. It 
has been included in the 
pharmacopoeia of 26 countries. It 
has been shown that amino acids, 
polysaccharides, fatty acids, 
essential oils, mineral elements, 
flavonoids, and other phenolic 
compounds are the main constituents 
of Matricaria chamomilla (6, 7). 
Preparations (e.g. ointments, 
inhalations, tinctures, teas) of 
chamomile are using in modern 
medicine primarily for their 
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spasmolytic, antiphlogistic, anti-
inflammatory, and antibacterial 
properties (8, 9, 10). One of the 
chamomile’s main roles is its use as 
a multipurpose digestive aid to treat 
gastrointestinal disturbances 
including flatulence, indigestion, 
diarrhea, anorexia, motion sickness, 
nausea, and vomiting. Chamomile is 
thought to heal ulcers and acts as an 
herbal bitter to stimulate the liver. It 
has been shown that the extracts 
from this plant, singly or combined 
with other plants have 
antiulcerogenic activity (11). 
Terminalia chebula (Haritaki) is 
another anti-ulcer agent containing 
active ingredient including; 
glycosides such as triterpenes 
arjunglucoside I, arjungenin, and 
chebulosides I and II also phenolic 
compounds such as ellagic acid, 2,4-
chebulyl-D-glucopyranose, 
chebulinic acid, gallic acid, ethyl 
gallate, punicalagin, terflavin A, 
terchebin, luteolin, and tannic acid. 
Terminalia chebula preparations 
used in many conditions like 
digestive disorders, irregular fevers, 
flatulence, and constipation (12). It 
is the best bowel cleanser and can be 
helpful emptying the stomach in a 
safer way. Terminalia cheubla is 
basically astringent, mild and safe 
purgative, stomachic (13), 
antioxidant, anti-tumor (14) and mild 
laxative. It has been helpful in 
various conditions particularly 
asthma, piles and cough. It is also 
useful in healing of wounds and 
scalds. It can be used as gargle 
against inflammation of mucous 
membrane in the mouth (15). 
Terminalia cheubla is also used for 
ulcers (16), vomiting, colic pain 
urinary infections, diabetes, skin 
diseases, parasitic infections, heart 
diseases, and hemorrhoids (15). 
     The aim of the present study was 
to investigate and to compare the 
mucosal protective effect of oral 
monotherapy with ethanolic extracts 
of  chamomile and Haritaki with 
Asacol, as a reference anti-
inflammatory drug in the 
experimental model of GAA5% 
induced UC in rabbits. 
 
Materials and Methods: 
Animals:                                                                                            
    Twenty four healthy, local, 
domestic rabbits weighing (750-
1600) gm of both sexes were used in 
this study. They were supplied by 
the local animal market at Al-Hilla 
city. All rabbits were housed two per 
cage, which was provided with a 
wire mesh floor. They were fed 
standard oxoid pellets and given 
water ad libitum.                                                   
Medicinal plants: 
     Flowers of Matricaria 
chamomilla (Chamomile) and fruits 
of  Terminalia chebula (Haritaki) 
were dried and used in the present 
study. These plant materials were 
purchased from the local market and 
identified by the National Iraqi 
Institute for Herbs, Baghdad, Iraq.                                
Preparation of plant extract: 
        Ethanolic extracts were 
accomplished according to the 
method of le Grand (17). Briefly 50 
gm of each powdered plant sample 
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was mixed with 250 ml of 96% 
ethanol. The mixture was kept for 2-
5 days in tightly sealed containers at 
room temperature and shacked 
several times daily. This mixture 
was filtered through filter paper to 
remove the coarse plant materials. 
Further extraction of the residue was 
repeated 3-5 times until a clear 
supernatant extraction liquid was 
obtained. The filtrates of each tested 
plant were evaporated to dryness 
using a rotary evaporator at 40ºC. 
The final dried samples were 
weighed and stored at -20ºC until 
use.                                              
Experimental design and animal 
grouping:            
     Animals were divided into 4 
groups (six animals in each group).  
Ulcerative colitis was induced in 
each group by using a method of 
Jabir (18). In brief, Five ml of glacial 
acetic acid (GAA) was diluted in a 
volumetric flask with 20 ml of 
distilled water, then 30 ml of 99.8% 
ethanol was added to the flask, and 
then distilled water (DW) was added 
to a final volume of 100 ml. this 
solution was kept in a glass 
container away from light and sealed 
tightly, to be used for induction of 
colitis. All the animals were food 
withheld 24 hours before induction 
of colitis. The animal was 
anaesthetized by using of chloroform 
soaked cotton piece applied over its 
nose and stretched straight on the 
table then a rubber catheter (2 mm 
outer diameter) was inserted into the 
lumen of the colon via the anus. The 
catheter was advanced so that the tip 
was about 8 cm proximal to the anus 
(19). One ml of GAA 5% was 
instilled into the lumen of the colon 
using a syringe connected to the 
catheter. The animal was kept 
stretched (in a horizontal position) 
10 to 20 seconds to prevent rapid 
spillage of the solution. Then the 
animal was transferred to its cage. 
One hour later, all the animals were 
allowed to have free access to food 
and water. The first group (control 
group) was received 10 ml of DW 
orally as a single daily dose. The 
second group was given Asacol 
(Mesalazine (Asacol)
®
 : 800 mg 
enteric coating tablets-10 tablets, 
Tillotts Pharma-Swizerland) at a 
dose of 800 mg/kg BW dissolved in 
10 ml of DW and administered as a 
single daily dose orally 
(Pretreatment was to enhance tissue 
repairing and to prevent or attenuate 
the severity of colonic ulceration that 
could be later produced by GAA 
5%). The third group was given 
ethanolic extract of chamomile at a 
dose of 500 mg/kg BW dissolved in 
10 ml of DW administered as a 
single daily dose orally. And finally 
the fourth group was given ethanolic 
extract of Haritaki at a dose of 1000 
mg/kg BW dissolved in 10 ml of 
DW administered as a single daily 
dose orally. 
    Each agent (including DW) was 
administered  two days prior to 
induction of colitis, the day of 
induction, and a dose 22 hours post-
induction (i.e., 2 hours prior to 
sacrificing of the animal). 
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Blood sampling: 
 .  Blood samples were taken for 
biochemical and haematological 
analysis at 2 occasions:-  
1-at the beginning of experiment  
(before induction of UC) to 
determine the normal values of 
serum sodium, serum potassium,  
total WBC, lymphocyte count, RBC 
count, HGB, and PCV% of the 
tested animals.  
2-at the end of experiment (i.e., 24 
after induction of UC)  
     Blood samples were obtained 
from the heart; 5 ml of blood could 
be aspirated in each occasion.  
Biochemical examination of sera: 
     Serum sodium and potassium 
were estimated by using of flame 
photometer (ELICO
®
 , CL378-
England) according to the method of  
(20). 
Haematological assessment: 
     Estimation of total WBC count 
has been carried out using 
hemocytometer with Neubaur 
improved double slide and Thomas's 
solution as a diluent (21). Where as 
lymphocytes count has been 
calculated in Leishman's stained 
blood smears by using of oil 
immersion (21). Estimation of RBC 
has been carried out using 
hemocytometer and Hayem’s fluid 
as a diluent (20). HGB was tested by 
using of Sahli's hemoglobinometer 
method (Haemometer: 
MAREINFELD Laboratory 
glassware-Germany) (22). PCV% 
was assessed by using of haematocrit 
centrifuge (HAEMATOKRIT 20, 
Hettich ZENTRIFUGEN-Germany). 
Colon isolation and preparation: 
     At the end of experiment, the 
animals were sacrificed, the 
abdomen was opened longitudinally, 
and a segment of colon 8 cm 
proximal to the anus was removed 
for assessment of colonic 
inflammation and ulceration. The 
excised colonic segment was 
immediately immersed in normal 
saline, cleaned from adherent 
tissues, opened longitudinally and 
then rinsed with 0.9% sodium 
chloride solution to discard the fecal 
materials (18). 
Gross examination:  
     The segment was put on a clean 
white tray and examined grossly 
with the naked eye in order to 
examine the changes. 
Histopathological examination: 
     After gross examination of the 
colon segments, they were placed in 
formalin 10% to be ready for 
sectioning which was carried out at 
Al-Karameh Hospital. The 
histopathological examination of the 
sections was then done to check the 
microscopic changes of the colon 
tissue by using light microscopy. 
Statistical analysis:  
    The values are given as mean±SE, 
P<0.05 and P<0.01  were used as a 
criterian for significance. The data 
were analyzed by student’s t-test 
using SPSS (Version 10).  
                                
Results: 
    By the end of experiments, i.e., 24 
hours after the rabbits being 
intrarectally administered by 1 ml of 
GAA 5%, colonic inflammation and 
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ulceration occurred in all of the 
studied animals with severity and 
extent that varied from group to 
another and the following results 
were detected: 
Serum electrolyte levels (sodium 
and potassium): 
     Control group showed significant 
reduction in the levels of serum 
sodium and serum potassium at p 
<0.05 (150.6±12.63 mmol/l, 
0.2±0.03 mmol/l respectively) 
revealing hyponatraemia and 
hypokalaemia in comparison to the 
normal values (423.63±40.85 
mmol/l, 0.98±0.07 mmol/l 
respectively). 
    Asacol group showed significant 
elevation in the levels of serum 
sodium and serum potassium at p 
<0.05 (306.33±13.47 mmol/l, 
0.58±0.03 mmol/l respectively). 
Chamomile group showed 
significant elevation in the levels of 
serum sodium and serum potassium 
at p <0.05 (309.58±22.54 mmol/l, 
0.51±0.04 mmol/l respectively). 
Where as Haritaki group showed 
significant elevation in the levels of 
serum sodium and serum potassium 
at p <0.05 (318.91±25.60 mmol/l, 
0.53±0.07 mmol/l respectively) 
when compared with the control 
group (Table 1). 
Total WBC count and lymphocyte 
count: 
     In control group, GAA 5% 
produced severe inflammation of 
colon assessed by significant 
elevation in the total WBC and 
lymphocyte count at p<0.05 
(3.18±0.45 X10
3/μl, 1.68±0.23 
X10
3/μl respectively) in comparison 
to the normal values (1.4±0.03 
X10
3/μl, 0.73±0.03 X103/μl). Asacol 
group showed significant reduction 
in the total WBC and lymphocyte 
count at p<0.05 (2.01±0.10 X10
3/μl, 
0.96±0.05 X10
3/μl respectively). 
Chamomile group showed 
significant reduction in the total 
WBC and lymphocyte count at 
p<0.01 (2.5±0.07 X10
3/μl, 1.28±0.06 
X10
3/μl respectively). While, 
Haritaki group showed significant 
reduction in the total WBC and 
lymphocyte count at p<0.01 
(2.41±0.12 X10
3/μl, 1.25±0.07 
X10
3/μl respectively) when 
compared with the control group 
(Table 2,  3).  
RBC count, HGB level, and 
PCV%: 
     Control group revealed 
significant reduction in the count of 
RBC, HGB level, and percentage of 
PCV% at p<0.05 (4.35±0.09 
X10
6/μl, 9.25±0.09 gm/dl, 
32.5±0.67% respectively) when 
compared with the normal values 
6.08±0.08 X10
6/μl, 14.4±0.14 gm/dl, 
60.16±2.17% respectively). Asacol 
group showed significant elevation 
in the RBC count, HGB level, and 
percentage of PCV% at p<0.05 
(5.11±0.07 X10
6/μl, 12.75±0.10 
gm/dl, 45±0.96% respectively). 
Chamomile group showed 
significant elevation in the RBC 
count, HGB level, and percentage of 
PCV% at p<0.05 (4.92±0.03 
X10
6/μl, 12.58±0.15 gm/dl, 
42±0.51% respectively). And finally, 
Haritaki group showed significant 
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elevation in the RBC count, HGB 
level, and percentage of PCV% at 
p<0.05 (5.02±0.14 X10
6/μl, 
12.7±0.07 gm/dl, 48.83±1.14% 
respectively) (Table 4, 5, 6). 
Gross examination: 
    The induced histological damage 
was grossly obvious in the control 
group; it showed clear ulcer, severe 
erosion of the tissue, severe 
congestion, and severe hemorrhage 
(Figure 2, 3). Colon segments of 
Asacol group showed no ulcer, no 
erosion, mild congestion, and no 
hemorrhage (Figure 4). Where as 
colon segments of the Chamomile 
and Haritaki groups showed erosion, 
congestion, and mild hemorrhage 
without ulceration (Figure 5, 6).  
Histopathological examination: 
    Histological sections of the 
control group showed severe 
complete sloughing of epithelium 
and sever hemorrhage in sub-
epithelial layer (Figure 8,9). Colon 
of Asacol group showed 
regeneration of epithelium, mild 
fibrosis in sub-epithelial layer and 
hyperplasia in smooth muscles 
(Figure 10, 11). Colon of the 
Chamomile group showed less 
severe changes, when compared to 
the control group, but complete 
sloughing of epithelium and mild 
hemorrhage in sub-epithelial layer 
could be seen (Figure 12, 13). Colon 
of the Haritaki group showed 
complete regeneration and 
hyperplasia of epithelium congestion 
and severe fibrosis in sub-epithelial 
layer (Figure 14, 15). 
 
Table (1): Serum sodium and potassium levels (M±SE, n=6) of control and 
treatment groups, measured pre- and post-induction of UC by GAA 5%. 
 
Group Serum Sodium level 
(mmol/l) 
Serum Potassium level 
(mmol/l) 
Pre-
induction 
Post-
induction 
Pre-
induction 
Post-
induction 
Control 423.63±40.85 150.6±12.63 0.98±0.07 0.2±0.03 
Asacol 423.63±40.85 306.33±13.47 
* 
0.98±0.07 0.58±0.03 * 
Chamomile 
extract 
423.63±40.85 309.58±22.54 
* 
0.98±0.07 0.51±0.04 * 
Haritaki extract 423.63±40.85 318.91±25.60 
* 
0.98±0.07 0.53±0.07 * 
*Significant elevating effect at p<0.05 
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Table (2): Total WBC count (M±SE, n=6) of the control and treatment groups 
measured pre- and post-induction of UC by GAA 5%. 
Group Total WBC count (X10
3
/μl) 
Pre-induction Post-induction 
Control 1.4±0.03 3.18±0.45 
Asacol 1.4±0.03 2.01±0.10 * 
Chamomile extract 1.4±0.03 2.5±0.07 ** 
Haritaki extract 1.4±0.03 2.41±0.12 ** 
* Significant lowering effect at p<0.05. 
** Insignificant lowering effect at p<0.05, but it have significant lowering 
effect at p<0.01. 
 
Table (3): Lymphocyte count (M±SE, n=6) of the control and treatment groups 
measured pre- and post-induction of UC by GAA 5%. 
Group Lymphocyte count (X10
3
/μl) 
Pre-induction Post-induction 
Control 0.73±0.03 1.68±0.23 
Asacol 0.73±0.03 0.96±0.05 * 
Chamomile extract 0.73±0.03 1.28±0.06 ** 
Haritaki extract 0.73±0.03 1.25±0.07 ** 
* Significant lowering effect at p<0.05. 
** Insignificant lowering effect at p<0.05, but it have significant lowering 
effect at p<0.01. 
 
Table (4): RBC count (M±SE, n=6) of the control and treatment groups 
measured pre- and post-induction of UC by GAA 5%. 
Group RBC count (X10
6
/μl) 
Pre-induction Post-induction 
Control 6.08±0.08 4.35±0.09 
Asacol 6.08±0.08 5.11±0.07 * 
Chamomile extract 6.08±0.08 4.92±0.03 * 
Haritaki extract 6.08±0.08 5.02±0.14 * 
*Significant elevating effect at p<0.05. 
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Table (5): HGB level (M±SE, n=6) of the control and treatment groups 
measured pre- and post-induction of UC by GAA 5%. 
Group HGB level (gm/dl) 
Pre-induction Post-induction 
Control 14.4±0.14 9.25±0.09 
Asacol 14.4±0.14 12.75±0.10 * 
Chamomile extract 14.4±0.14 12.58±0.15 * 
Haritaki extract 14.4±0.14 12.7±0.07 * 
* Significant elevating effect at p<0.05. 
 
 
Table (6): Percentage of PCV (M±SE, n=6) of the control and treatment groups 
measured pre- and post-induction of UC by GAA 5%. 
Group PCV% 
Pre-induction Post-induction 
Control 60.16±2.17 32.5±0.67 
Asacol 60.16±2.17 45±0.96 * 
Chamomile extract 60.16±2.17 42±0.51 * 
Haritaki extract 60.16±2.17 48.83±1.14 * 
* Significant elevating effect at p<0.05. 
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Figure (1): normal rabbit colon segment. 
 
 
Figure (2): rabbit colon seen at labaratomy of the control group showed severe 
inflammation, severe congestion, and hemorrhage.  
 
 
                   
Figure (3): rabbit colon segment of the control group showed ulcer, severe 
erosion of the tissue, severe congestion, and severe hemorrhage caused by 
GAA5%. 
 
 
Figure (4): rabbit colon segment of the group treated by Asacol showed no 
ulcer, no erosion, mild congestion, and no hemorrhage. 
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Figure (5): rabbit colon segment of the group treated by ethanolic extract of 
Matricaria chamomilla showed erosion, congestion, and mild hemorrhage 
without ulceration. 
 
 
 
 
 
 
 
 
 
 
 
Figure (6): rabbit colon segment of the group treated by ethanolic extract of 
Terminalia chebula showed erosion, congestion, and mild hemorrhage without 
ulceration. 
 
 
 
 
 
 
 
Figure (7): normal rabbit colon showed 
normal intestinal tissue, normal epithelium 
(arrow).   50X H&E stain. 
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Figure (8): colon of the control group 
showed severe complete sloughing of 
epithelium (arrows) and hemorrhage in sub-
epithelial layer. 50X H&E stain. 
 
Figure (9): colon of the control group 
showed severe complete sloughing of 
epithelium (arrows) and sever hemorrhage 
in sub-epithelial layer. 50X H&E stain. 
Figure (10): colon of the Asacol group 
showed regeneration of epithelium (arrows), 
congestion in sub-epithelial layer and 
hyperplasia in smooth muscles. 50X H&E 
stain. 
 
Figure (11): colon of Asacol group showed 
regeneration of epithelium (arrows), mild 
fibrosis in sub-epithelial layer (arrow) and 
hyperplasia in smooth muscles. 50X H&E 
stain. 
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Figure (12): colon of the Chamomile group 
showed less severe, but complete  sloughing 
of epithelium (arrow) and  mild hemorrhage 
in sub-epithelial layer (arrow) . 200X H&E 
stain. 
 
Figure (13): colon of the Chamomile group 
showed less severe, but complete  sloughing 
of epithelium (arrows),  hemorrhage and 
congestion in sub-epithelial layer (short 
arrow). 200X H&E stain. 
 
Figure (14): colon of Haritaki group showed 
complete regeneration and hyperplasia of 
epithelium (arrows), congestion and severe 
fibrosis in sub-epithelial layer.50X H&E stain 
stain. 
 
 
 
Figure (15): colon of the Haritaki group showed 
complete regeneration and hyperplasia of 
epithelium (arrow), congestion and severe 
fibrosis in sub-epithelial layer. 50X H&E stain. 
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Discussion: 
    Various animal models have 
provided a foundation for future 
investigation into the mechanisms 
responsible for UC, which will 
hopefully result in the development 
and testing of novel therapeutic 
regimens (23). Glacial acetic acid-
induced colitis is used widely 
because of its reproducibility (with 
lesions occurring in 100% of 
animals). In addition, it provides an 
inexpensive model useful in 
comparing the effectiveness of novel 
therapeutic agents (24). Its similarity 
with human UC in many aspects 
make researchers still use it as one 
of the models of induced colitis. In 
the present study, ethanol was used 
in combination with acetic acid 
(5%GAA-30%  Ethanol) in order to 
decrease the mucosal barrier 
(18).The schedule of therapy (2 days 
before, the day of induction, and 22 
hours after induction of colitis by 
GAA5%) was dependent in this 
study to evaluate mainly the possible 
prophylactic role of the tested agents 
in addition to their effectiveness in 
initial therapy for acute attacks of 
colitis. Blood samples were 
collected from all of the tested 
rabbits prior to the beginning of 
experiment and in the last day, the 
day of animal sacrificing. 
Measurement of serum electrolytes 
(sodium and potassium), 
haematological parameters (total 
WBC count, lymphocyte count, 
RBC count, HGB, PCV%) besides 
gross and microscopical examination 
of colon sections was dependent to  
 
assess the severity of symptoms of 
UC among the tested groups (control 
and treatment groups). The present 
study showed that the rectal 
administration of 1 ml of 5%GAA-
30%ethnol to the control group 
could produced hyponatraemia, 
hypokalaemia, severe inflammation 
indicated by leukocytosis and 
lymphocytosis, also it induced 
congestion and hemorrhage revealed 
by erythrocytopenia, low HGB level 
and low PCV%. Where as gross 
examination of colon segment 
showed severe ulceration, erosion, 
and hemorrhage. These symptoms 
were similar to those mentioned in 
the diagnosis of UC in the review of 
literatures in addition to the 
histopathological changes that were 
proven by Jabir (18). 
   Mesalazine or called Asacol 
(active metabolite of sulfasalazina), 
the oral anti-inflammatory-delayed 
release tablets used commonly as a 
standard therapy to control acute 
attacks of UC. It is also thought to 
be an antioxidant that traps free 
radicals, which are potentially 
damaging byproducts of metabolism 
so it was used in the present study as 
what is called a positive control. 
Because the dose of oral Asacol in 
human is 1.6 gm divided into two 
times (25, 26) and the reproduction 
studies with sulfasalazina 
compounds in rats and rabbits at 
doses of 800 mg/kg BW or up to six 
times the human dose have not 
shown impaired female fertility or 
harmful effects (27, 28), so this 
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pushed us to test several doses of 
Asacol, they were 200, 400, 800 
mg/kg BW, but the most effective 
dose in reducing damaging effect of 
GAA5% on rabbit colon was 800 
mg/kg BW/day p.o, where as the 
others were discluded. Oral 
administration of Asacol had 
significantly elevated serum 
electrolyte levels, decreased 
inflammation, reduced blood loss, 
and prevented the colonic ulceration. 
Also the present study indicates that 
slow release 5-amino-salicylic acid 
at the larger dose reaches the large 
bowel in sufficiently high 
concentrations following oral 
administration and significantly 
reduces GAA5%-induced colitis in 
the rabbits when compared with the 
control group and other treatment 
groups. Kitano et al. ,(29) had 
demonstrated that Mesalazine 
microgranules (50 or 150 mg/kg 
BW/day) which were administered 
orally to each rabbit with 
carrageenan-induced colitis for six 
weeks, showed inhibitory effect on 
colonic mucosal damage. 
    Third group of rabbits were 
treated orally with ethanolic extract 
of Chamomile in various doses 
ranging from 300 mg/kg BW to 500 
mg/kg BW. The effective dose was 
500 mg/kg BW, since this dose 
elicited a maximum reduction in 
lesion severity and revealed accepted 
anti-ulcer effect, it produced 
significant elevation in the serum 
electrolyte levels, reduce 
inflammation and degree of 
hemorrhage as it assessed by 
biochemical and haematological 
tests, as well as it reduced the gross 
and microscopical changes 
characteristic of experimental UC. 
Anti-ulcer effect of chamomile was 
proven by Karbalay-Doust and 
Noorafshan (11), through using its 
aqueous extract at a dose of 400 
mg/kg BW p.o in an experimental 
model of gastric ulcer in mice. 
Chamomile extract contains many 
components that may exert anti-ulcer 
effects. Amino acids, 
polysaccharides, and fatty acids are 
some of its constituents. The flowers 
of chamomile contain 1-2% volatile 
oils including α-bisabolol, α- 
bisabolol oxides A & B, matricine, a 
variety of mineral elements 
including manganese and 
magnesium (30). Flavonoids and 
other phenolic compounds have been 
identified in various parts of the 
chamomile flower head. Apigenin, 
quercetin, patuletin, luteolin and 
their glucosides are the major 
flavonoids present in the flower. The 
presence of large amounts of 
cinnamic acid derivatives, frolic and 
caffeic acid, as well as other 
unidentified phenolic derivatives of 
the total flower has been 
investigated. All of the constituents, 
which have also been found in other 
plants, may have therapeutic effects 
(11). Here we reported the anti-ulcer 
effects of chamomile flower extract 
on acute experimental UC in rabbits. 
Our results are consistent with 
Khayyal and co-workers (31), they 
have shown that the extracts from 
the plant Matricaria recutita alone 
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or in combination with other plants 
have antiulcer activity. They have 
reported that the cytoprotective 
effect of the herbal extracts could be 
partly caused by their flavonoid 
content and to their free radical 
scavenging properties. 
    Ethanolic extract of Haritaki was 
given to the animals (forth group) at 
a different doses 500 mg/kg BW, 
and 1000 mg/kg BW daily via oral 
route, but the effective dose was 
1000 mg/kg BW because it produced 
significant increment in the levels of 
serum sodium and potassium, 
besides significant reduction in the 
inflammation by its anti-
inflammatory activity, and desirable 
mucosal protective effect against the 
ulcerogenic action of GAA5% on 
the colon of experimental animals. 
The mucosal protective and anti-
ulcer properties of Haritaki extract 
were demonstrated by Devi et al., 
(16) who found that the treatment of 
rats with methanolic extract of 
Haritaki at a dose of 500 mg/kg 
BW/day p.o could produced 
significant reduction in lesion index 
in rats suffering from diclofenac-
induced gastric ulcer confirming the 
gastroprotective activity of Haritaki 
extract which probably related to its 
free radical scavenging activity, 
antioxidant affectivity, and 
cytoprotective nature. So Hazra et 
al., (15) had proven the scavenging 
activities of the methanolic extract of 
Haritaki fruits which contains 
significant amount of  phenolic 
contents including ellagic acid, 2,4-
chebulyl-D-glucopyranose, 
chebulinic acid, gallic acid, ethyl 
gallate, punicalagin, terflavin A, 
terchebin, luteolin, and tannic acid.  
     These compounds have good 
antioxidant potential and their 
effects on human nutrition and 
health are considerable. Phenolic 
contents are also very important 
plant constituents because of their 
scavenging ability due to their 
hydroxyl groups (15). 
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